News

Green Hygienics launches tree-free, bamboo-based bath tissue

BY Jason Owen

MIAMI — A new line of tree-free, bamboo-based bath tissue from Green Hygienics, Inc. (GHI) is set to launch on retail shelves.

The exclusive license agreement will make this bath tissue the first ever tree-free, bamboo fiber-based toilet paper product available in North America, the company stated. The new products will be sold under GHI’s Sensational brand.

"The bath tissue market in North America is absolutely enormous, valued at an estimated $21.6 billion annually, and we feel that tree-free bamboo is going to quickly establish itself as the fastest growing and highest margin component of the industry," stated Philip Rundle, CEO of Green Innovations. "Our supply partners are at the cutting edge of the manufacturing capabilities that make these eco-friendly products possible on a global volume scale. Through our exclusive licensing deal, we intend to take advantage of our first to market status by quickly launching the new tree-free bamboo-based ‘Sensational’ branded bath tissue across North America. We feel it could rapidly become our highest demand product and provide significant revenues to the company."

GHI is currently finalizing samples and packaging for the North American market and expects to be offering product to wholesalers and retailers in less than 60 days. For an advanced look at the new tree-free bamboo-based Sensational tissue paper packaging design, interested parties are encouraged to visit the Company website at www.greeninnovationsltd.com/sensational/bamboo.html.


Like this story? Find us on Facebook for more insight, analysis and the latest in drug store news. Join the conversation.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

News

Cardinal Health posts fewer sales but greater profits vs. Wall Street expectations

BY Michael Johnsen

DUBLIN, Ohio — Cardinal Health on Thursday reported fiscal year 2013 third-quarter revenue of $24.6 billion, a 8.9% decline as compared with the quarter a year ago. 

However, Cardinal Health reported net earnings per share of $1.01, up 5.2%. According to published reports, Wall Street had been expecting greater revenue of $24.7 billion but at a lesser gain with earnings expectations estimated around 96 cents per share. 

"We delivered another solid performance in our fiscal third quarter," stated George Barrett, chairman and CEO of Cardinal Health. "Both our pharmaceutical and medical segments reported double-digit profit growth."  

Following the quarterly report, the wholesaler raised its fiscal 2013 outlook for non-GAAP diluted EPS from continuing operations to a range between $3.67 and $3.71. The revised range includes the $0.18 tax settlement previously mentioned.

Cardinal Health also announced that its board of directors approved a 10% increase in the company’s quarterly dividend to $0.3025 per share, or $1.21 per share on an annualized basis. The quarterly dividend is payable on July 15 to shareholders of record at close of business on July 1.


Like this story? Find us on Facebook for more insight, analysis and the latest in drug store news. Join the conversation.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

News

Bayer to acquire Conceptus for $1.1 billion

BY Alaric DeArment

LEVERKUSEN, Germany — Bayer HealthCare will buy birth-control product maker Conceptus for $1.1 billion, the companies said.

Bayer said its $31-per-share purchase of the Mountain View, Calif.-based company would allow it to expand its selection of contraception products. Conceptus makes Essure, a non-surgical permanent birth-control method, and Bayer said it would allow the company to offer a complete range of short-term, long-term and permanent contraceptive methods for women.

"Bayer is committed to augmenting its organic growth with strategic bolt-on acquisitions," Bayer AG CEO Marijn Dekkers said. "The acquisition of Conceptus represents an excellent fit for our HealthCare business, specifically in the United States, the world’s most important healthcare market."

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES